Emerald Mutual Fund Advisers Trust’s Keros Therapeutics KROS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-155,347	Closed	-$2.46M	–	224
2024 Q4	$2.46M	Buy	155,347 +42,734	+38%	+$676K	0.15%	113
2024 Q3	$6.54M	Buy	+112,613	New	+$6.54M	0.34%	95